(1) The Council shall in consultation with the Ministry of Health and the Pharmacy Council determine the quarterly price indices of drugs and medicines on the National Health Insurance Drug List and for which re-imbursement is to be paid by the schemes.

(2) Based on the quarterly indices, the Council shall in consultation with pharmaceutical service providers regularly set allowable percentage mark-up in the prices of drugs and medicines charged by health care facilities and re-imbursement shall only be made for drugs and medicines within the allowable mark-up price.